BIOME AUSTRALIA LTD ORDINARY (BIO) News
Latest articles and price-sensitive announcements with AI sentiment classification.
ASX
Biome Australia strikes deal to bring probiotics manufacturing onshore at SPA’s Gold Coast facility
Melbourne-based probiotics company Biome Australia (ASX: BIO) has signed a binding commercial manufacturing agreement to bring production of its Activated Probiotics range onshore, partnering with Specialty Probiotics Australia (SPA) at its Gold Coast facility in a deal that requires no upfront capital investment from Biome. The agreement targe...
Small Caps
Google NewsWhy Biome (ASX:BIO) Shares Are Up Today? - Kalkine
Why Biome (ASX:BIO) Shares Are Up Today? Kalkine
KalkineWhy Biome Australia Is Back in the Spotlight
Highlights Biome Australia continues attracting attention as demand for health and wellness products grows. Market expectations remain closely tied to future earnings expansion and business execution. The company operates in a rapidly evolving consumer health segment supported by growing awareness of gut health and probiotics. Biome Australia remains in focus as demand for probiotics, microbiome health products, and consumer wellness solutions continues to expand. Australia's health and welln...
Is Now The Time To Look At Buying Biome Australia Limited (ASX:BIO)? - simplywall.st
Is Now The Time To Look At Buying Biome Australia Limited (ASX:BIO)? simplywall.st
Patent Application Filed for Probiotic Strain BMB18
other announcement
Biome Australia Limited(ASX: BIO) dropped from S&P/ASX Emerging Companies Index - marketscreener.com
Biome Australia Limited(ASX: BIO) dropped from S&P/ASX Emerging Companies Index marketscreener.com
Biome Australia Move Signals Shift in Market Focus
Highlights Targeted capital move reflects strategic funding approach Market activity highlights shifting sentiment in small-cap space Liquidity and positioning continue to shape short-term behaviour Biome Australia’s targeted placement reflects funding discipline, highlighting liquidity-driven behaviour and evolving sentiment across Australia’s small-cap segment. Australia’s short selling sector often reveals how sentiment evolves beneath the surface of the broader ASX...
Ethics Approval Granted for BMB18 Human Clinical Trial
other announcement
Date of AGM and Closing Date for Director Nominations
other announcement